Skip to main content
. 2012 May 25;7(5):e37776. doi: 10.1371/journal.pone.0037776

Table 2. TP53 sequencing results of 62 patients with primary localized (n = 40) or metastastic (n = 22) GIST.

Stage/tissue no.pts (n = 62) Mutation % Polymorphism (P72R) %
very low 5 0 0% 5 100%
low 10 0 0% 10 100%
moderate 9 1 (H193R) 11% 8 89%
high 16 0 0% 14 87%
metastatic 22 1 (H290P) 5% 20 91%